Keros Therapeutics (KROS) Stock: Buy, Sell, or Hold?
KROS - Keros Therapeutics, Inc. Common Stock
$11.08
-0.09 (-0.81%)
âŧ
5d:
-0.27%
30d:
-1.07%
90d:
+10.25%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When KROS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: KROS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: KROS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: KROS is currently trading at $11.08, which is considered fair relative to its 30-day fair value range of $10.54 to $11.31.
Technical Outlook: Technically, KROS is in a downtrend. Immediate support is located at $10.58, while resistance sits at $11.82.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (80th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $19.83 (+79.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KROS is in a downtrend. Immediate support is located at $10.58, while resistance sits at $11.82.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (80th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $19.83 (+79.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.54 -
$11.31
Company Quality Score
52/100
(HOLD)
Options IV Signal
80th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
59.2%
Protect Your Profits
Holding KROS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Options expensive (IV 80th percentile)
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 79.0% below Wall St target ($19.83)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.54 -
$11.31
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$2.58
(23.3%)
Support & Resistance Levels
Support Level
$10.58
Resistance Level
$11.82
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.67
Wall Street Target
$19.83
(+79.0%)
Revenue Growth (YoY)
-99.8%
Share & Embed Analysis
Last updated: September 12, 2026 7:06 PM ET
Data refreshes hourly during market hours. Next update: 8:06 PM
Data refreshes hourly during market hours. Next update: 8:06 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KROS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jean Jacques Bienaime
BUY
1000 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
Advanced KROS Option Strategies
Professional options setups generated by AI based on today's KROS price and gamma walls.
